Allen Institute
The Allen Institute is a Seattle-based nonprofit bioscience research organization founded in 2003 that runs six large-scale open-science "accelerators" (brain, cell, neural dynamics, immunology, synthetic biology, brain health) combining genomics, connectomics, AI and supercomputing, publishing all data and tools freely to the global research community and now expanding into gene-therapy development.
- Company typePrivate
- Founded2003
- HeadquartersSeattle, United States
- Headcount251–500
- GTM typeB2B
- OfferingServices
What Allen Institute does
The Allen Institute is a Seattle-based nonprofit bioscience research organization founded by Paul Allen in 2003 that operates six large-scale multidisciplinary research programs — Brain Science, Cell Science, Neural Dynamics, Immunology, Synthetic Biology (Seattle Hub), and Brain Health. Each "accelerator" combines single-cell genomics, connectomics, advanced imaging, and machine learning to map brain cells, immune cells and human cellular systems, with flagship outputs including a 1.6-petabyte mouse visual cortex reconstruction (MICrONS), a virtual mouse cortex simulation of 10 million neurons and 26 billion synapses built with Japan's Fugaku supercomputer, the Brain Knowledge Platform consolidating data from 34+ million cells across 22 species, and the iGluSnFR4 molecular glutamate indicator. The defining operational principle is a mandatory open-science mandate: every dataset, tool and model is published freely for noncommercial research through portals such as brain-map.org, allencell.org, allenimmunology.org, brain-bican.org, and microns-explorer.org, with structured APIs and the Code Ocean computational platform (v4.0, processing ~1.75M CPU hours and 150+ TB of reproducible output per month for ~250 researchers). The Institute earns no commercial revenue from its primary outputs; instead it is funded by philanthropy (notably Paul Allen's Fund for Science and Technology, the Bezos family), NIH/BRAIN Initiative federal grants, and technology partnerships with AWS, Google, NVIDIA, OpenAI and Anthropic. In June 2026 it launched the $400 million, 14-year Brain Health Accelerator — its first explicit therapeutic mandate, aimed at gene therapies for Alzheimer's, Parkinson's, Huntington's, ALS and Lewy body dementia with a stated goal of a clinical trial within five years — joining Biohub's $500 million Virtual Biology Initiative the same year. The AAV Viral Tools Collection, available for purchase, represents the institute's first move toward a hybrid open-plus-commercial tool model for gene-therapy developers.
Allen Institute firmographics
Firmographics- Name
- Allen Institute
- Legal name
- Allen Institute
- Website
- https://alleninstitute.org
- Company type
- Private
- Founded year
- 2003
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- The Allen Institute is a Seattle-based nonprofit bioscience research organization founded in 2003 that runs six large-scale open-science "accelerators" (brain, cell, neural dynamics, immunology, synthetic biology, brain health) combining genomics, connectomics, AI and supercomputing, publishing all data and tools freely to the global research community and now expanding into gene-therapy development.
- Ownership category
- akta.pro rank
Allen Institute industry classification
Industry- Product category
- Bioscience Research Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Voluntary Health Organizations (813212)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO)
- akta.pro secondary industries
- Neurology/CNS Gene Therapies (HLAAACAH), AI/ML-Enabled Biologic Discovery Platforms (computational design, in silico screening) (HLAAAIAE), Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)
Keywords
Where Allen Institute is headquartered
LocationHeadquarters
- HQ city
- Seattle
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Allen Institute business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales
Revenue model
- Philanthropic Funding: Primary funding from private philanthropists including the Bezos family ($100 million for Brain Health Accelerator) and Paul Allen's Fund for Science and Technology ($200 million for Brain Health Accelerator). Founded by Paul Allen in 2003.
- Federal Research Grants: Significant funding from NIH and other federal agencies for specific research initiatives including BRAIN Initiative projects and BICAN.
- Open Science Data Sharing: As a nonprofit bioscience research organization, the Institute provides all data, tools, and models as free open resources to accelerate global scientific discovery. No commercial revenue is generated from data sharing.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels7 records
Allen Institute product offering
Product offeringCore offering
The Allen Institute is a nonprofit bioscience research organization that conducts large-scale, team-based research initiatives across brain science, cell science, neural dynamics, immunology, synthetic biology, and brain health. It produces open datasets, tools, models, and reagents (including adeno-associated viral vectors), and shares all outputs freely with the global scientific community through dedicated web portals such as brain-map.org, allencell.org, and allenimmunology.org. Its newest offering, the Brain Health Accelerator launched in June 2026 with $400M in funding, is the Institute's first explicit effort to translate foundational research into gene therapies for Alzheimer's, Parkinson's, ALS, Huntington's, and Lewy body dementia.
Product overview
The Allen Institute is a nonprofit bioscience research organization founded by Paul Allen in 2003, operating through six interconnected research accelerators: Brain Science, Cell Science, Neural Dynamics, Immunology, Synthetic Biology (Seattle Hub), and Brain Health. The Brain Science accelerator maps brain cells, circuits, and connectivity through initiatives like the Brain Knowledge Platform (developed with AWS and Google), Brain Map portal, and MICrONS Explorer. Cell Science work centers on the Allen Cell Explorer. Immunology research is accessible through the Allen Immunology Explorer. The Brain Health Accelerator (launched June 2026 with $400M funding) represents the institute's first explicit focus on treating disease through gene therapy development. All research outputs are released as open resources including datasets, analysis tools, protocols, and code, accessible through dedicated portals like allencell.org, allenimmunology.org, allenneuraldynamics.org, brain-map.org, brain-bican.org, and microns-explorer.org. The Ivy Glioblastoma Atlas provides specialized cancer research data with a public API for data access.
Differentiator
Problem solved
Functional benefit
Brands
- Ivy Glioblastoma Atlas Project: A foundational resource for exploring the anatomic and genetic basis of glioblastoma at the cellular and molecular levels, developed in partnership with the Ben and Catherine Ivy Foundation.
Products and services
- Brain Science Accelerator Large-scale research program mapping every cell, connection, and circuit in the brain through initiatives such as the Brain Knowledge Platform, Brain Map, MICrONS Explorer, and Brain-BICAN, with outputs openly shared with the global scientific community.
- Cell Science Accelerator Research program decoding how cells become tissues and translating that knowledge into open research tools and models released through the Allen Cell Explorer.
- Neural Dynamics Accelerator Research program revealing how neural activity transforms into real-world behavior, with data and tools shared via the Allen Neural Dynamics portal.
- Immunology Accelerator Research program building the deepest open reference for the healthy human immune system, with tools and data released through the Allen Immunology Explorer.
- Synthetic Biology (Seattle Hub) Research program engineering cells to record their own histories, transforming how disease progression is understood over time.
- Brain Health Accelerator Disease-translation research program developing gene therapies for neurodegenerative conditions including Alzheimer's, Parkinson's, Huntington's, ALS, and Lewy body dementia, with the explicit goal of reaching clinical trial within five years.
- Brain Knowledge Platform AI-powered neuroscience research platform built with AWS and Google that unifies and standardizes brain cell data from over 34 million cells across 22 species, enabling pattern recognition and cross-dataset comparison to accelerate brain disease research.
- Allen Cell Explorer Open data portal providing free access to cell imaging data, predictive models, and analysis tools for cell biology researchers worldwide.
- Brain Map Open-access portal providing brain atlas data including cell types, connectivity, and gene expression across multiple species for neuroscience researchers.
- MICrONS Explorer Interactive exploration tool for the MICrONS Project's 3D reconstruction of mouse visual cortex, providing access to a 1.6 petabyte dataset of over 200,000 cells and 523 million synapses.
- Brain-BICAN Open data portal for the BRAIN Initiative Cell Atlas Network, providing developing-brain cell atlas data across mice, nonhuman primates, and humans.
- Allen Immunology Explorer Open reference resource providing data and analysis tools for research on the healthy human immune system.
- Allen Neural Dynamics Open resource providing neural dynamics research data and tools to the scientific community.
- Ivy Glioblastoma Atlas Project Foundational open resource for exploring the anatomic and genetic basis of glioblastoma at cellular and molecular levels, including ISH image and RNA-Seq data with a public data API.
- AAV Viral Tools Collection Collection of adeno-associated viruses (AAVs) engineered to target specific cell types in the brain and spinal cord, sold for use in understanding neural cell function and developing gene therapies.
Quantifiable outcome
- First detailed virtual mouse cortex simulation with 10 million neurons and 26 billion synapses
- +3 more outcomes
Companies that use Allen Institute
Customer profileNamed customers1 record
Segments5 records
Ideal customer profiles4 records
Allen Institute technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability9 records
Feature12 records
Allen Institute partnerships and signals
Strategic signalPartnerships
22 partnerships are on record, tiered core, major and minor.
- Amazon Web ServicescoreCloud computing infrastructure partner for Brain Health Accelerator and Brain Knowledge Platform, providing computational resources for large-scale data analysis and AI model training.
- EverythingALSmajorPartner in Brain Health Accelerator focused on ALS research, contributing to the goal of reaching clinical trial within five years.
- Biohub (Virtual Biology Initiative)core$500 million five-year initiative to create data foundation for AI models of the human cell, with Allen Institute as a key participating institution alongside Arc Institute, Broad Institute, Human Cell Atlas, Human Protein Atlas, and Wellcome Sanger Institute.
- NVIDIAcoreKey technology partner providing accelerated computing infrastructure for Virtual Biology Initiative to process massive datasets for AI model training.
- Arc InstitutemajorResearch partner in Virtual Biology Initiative focused on building massive biological datasets and AI models.
- Broad InstitutemajorResearch partner in Virtual Biology Initiative contributing to global data generation efforts.
- Wellcome Sanger InstitutemajorInternational research partner in Virtual Biology Initiative for human cell mapping and AI model development.
- Human Cell AtlasmajorPartner organization contributing to global cell mapping efforts within Virtual Biology Initiative.
- Human Protein AtlasmajorPartner organization contributing protein mapping data to Virtual Biology Initiative.
- 50×50: Science Across AmericaminorMedia initiative pairing YouTube creators with scientists across all 50 US states, with Allen Institute as a founding partner to promote science education and visibility.
- OpenAImajorEarly access partner for GPT-Rosalind, OpenAI's first domain-specific AI model for life sciences research, applying the model to scientific workflows for evidence synthesis, hypothesis generation, and experimental planning.
- AmgenmajorPharmaceutical partner for GPT-Rosalind AI model testing and application in drug discovery workflows.
- ModernamajorBiotechnology partner applying GPT-Rosalind AI model to mRNA and drug discovery research workflows.
- Thermo Fisher ScientificmajorLife sciences tools company partnering to apply AI models in research workflows and experimental planning.
- Japan RIKEN Center for Computational SciencemajorCollaborative partner on Fugaku supercomputer mouse cortex simulation project, combining datasets with Japan's computational power.
- Code OceanmajorAWS-based computational research platform adopted by Allen Institute, enabling reproducible research with secure access to agentic AI within AWS environments.
- AWS (Amazon Web Services)coreCloud infrastructure provider for Code Ocean platform and Brain Health Accelerator, enabling processing of 1.75 million CPU hours and 150+ TB monthly.
- AnthropicmajorCollaboration to integrate AI into biological research workflows, focusing on scientific data analysis, hypothesis generation, and experimental interpretation.
- HHMI (Howard Hughes Medical Institute)majorPartnership on life sciences AI integration and collaborative research, including Janelia Research Campus collaboration on iGluSnFR4 glutamate indicator technology.
- University of Electro-Communications (Japan)majorAcademic partner on virtual brain simulation using Fugaku supercomputer, providing datasets and research expertise.
- GooglecoreContributing to the Brain Knowledge Platform, an AI-based neuroscience research tool that unifies diverse brain data from multiple sources using Google's infrastructure and AI capabilities.
- Swedish Neuroscience InstitutemajorClinical partner in Ivy Glioblastoma Atlas Project, providing research expertise and patient samples for brain tumor mapping.
Scale indicators10 records
Recent moves7 records
Expansion highlights7 records
Allen Institute competitors and assessment
Company assessmentDirect peers
- Broad Institute: The Broad Institute is a leading genomics and biomedical research organization and a co-participant in Biohub's Virtual Biology Initiative alongside Allen Institute. Both operate elite nonprofit research programs spanning genomics, cell biology, and disease, and compete for similar federal funding and scientific talent pools.
- Chan Zuckerberg Biohub: CZ Biohub launched the $500M Virtual Biology Initiative in which Allen Institute is a key participating institution. Biohub operates an open science research model similar to Allen's, focused on AI-driven biological research, making it a direct peer and partner in the shared goal of building foundational AI models of human biology.
- Salk Institute for Biological Studies: The Salk Institute is a prestigious nonprofit biological research organization focused on molecular biology, neuroscience, and genetics. Both Allen Institute and Salk operate large-scale interdisciplinary research programs, compete for NIH funding and scientific talent, and emphasize open publication of research findings.
- Wellcome Sanger Institute: Wellcome Sanger Institute is one of the world's leading genomic research centers and a co-participant in Biohub's Virtual Biology Initiative alongside Allen Institute. Both organizations generate large-scale biological reference datasets shared openly with the global research community, and Sanger's cell atlas work directly complements Allen's cell science accelerator.
- Cold Spring Harbor Laboratory: Cold Spring Harbor Laboratory is a private nonprofit research and education institution focused on cancer, neuroscience, and quantitative biology. Both organizations operate as elite nonprofit research institutes with similar funding models (federal grants plus philanthropy), compete for similar talent, and contribute open research resources to the global scientific community.
- Whitehead Institute: Whitehead Institute is a leading nonprofit biomedical research organization affiliated with MIT. Both operate as elite private research institutes focused on fundamental biological discovery, share open science principles, and compete for federal research funding and principal investigator talent in genomics and cell biology.
- Arc Institute: Arc Institute is a nonprofit research organization focused on the intersection of AI and biology, founded in 2021. It is a direct peer to Allen Institute, co-participating in the Virtual Biology Initiative, and represents an emerging competitor in the AI-driven bioscience research space with significant venture backing.
Broad incumbents
- Howard Hughes Medical Institute (HHMI): HHMI is the largest private biomedical research organization in the US and a direct peer to the Allen Institute. Both operate as nonprofit research organizations funding long-term basic science with substantial endowments. HHMI's Janelia Research Campus is an explicit Allen partner (iGluSnFR4 development) and operates a comparable model of large-scale interdisciplinary neuroscience research.
- Chan Zuckerberg Initiative (CZI): CZI is a major philanthropic biomedical research funder and the parent organization of Chan Zuckerberg Biohub. CZI's Science program funds large-scale biomedical research and infrastructure (including the Human Cell Atlas), placing it in direct competition with Allen Institute for philanthropic capital and research influence in open bioscience.
Regional players
- European Molecular Biology Laboratory (EMBL): EMBL is Europe's flagship life sciences research organization, operating across multiple countries with research programs in structural biology, genomics, and bioinformatics. EMBL's European Bioinformatics Institute (EBI) is a direct peer to Allen's open data platforms, and both compete in setting global standards for open biological data.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Allen Institute social profiles
Digital presenceAllen Institute financial estimates
Financial estimateRevenue estimate
Valuation estimate
Allen Institute leadership team
Management profileNumber of profiles
Allen Institute funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Allen Institute M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Allen Institute
What does Allen Institute do?
The Allen Institute is a nonprofit bioscience research organization that conducts large-scale, team-based research initiatives across brain science, cell science, neural dynamics, immunology, synthetic biology, and brain health. It produces open datasets, tools, models, and reagents (including adeno-associated viral vectors), and shares all outputs freely with the global scientific community through dedicated web portals such as brain-map.org, allencell.org, and allenimmunology.org. Its newest offering, the Brain Health Accelerator launched in June 2026 with $400M in funding, is the Institute's first explicit effort to translate foundational research into gene therapies for Alzheimer's, Parkinson's, ALS, Huntington's, and Lewy body dementia.
Is Allen Institute a public or private company?
Allen Institute is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Allen Institute founded?
Allen Institute was founded in 2003. It employs 251 to 500 people.
Where is Allen Institute based?
Allen Institute is headquartered in Seattle, United States, in the North America region.
How does Allen Institute make money?
Three revenue lines are on record. Philanthropic Funding is the primary driver. The others are federal Research Grants and open Science Data Sharing.
Who are Allen Institute's main competitors?
Direct peers on record are Broad Institute, Chan Zuckerberg Biohub, Salk Institute for Biological Studies, Wellcome Sanger Institute, Cold Spring Harbor Laboratory, Whitehead Institute and Arc Institute. Broad incumbents are Howard Hughes Medical Institute (HHMI) and Chan Zuckerberg Initiative (CZI). European Molecular Biology Laboratory (EMBL) is listed as a regional player.
Does Allen Institute have an API?
Yes. The Ivy Glioblastoma Atlas Project provides a public API for data access, including tumor details, anatomic structure information, gene expression data, and RNA sequencing sample details. The API offers endpoints for downloading datasets including normalized gene-level FPKM values, un-normalized FPKM and TPM values, anonymized BAM files, and reference genomes. Data is returned in CSV format via well-known file download endpoints. Developer documentation is at glioblastoma.alleninstitute.org/static/download.html.
What industry is Allen Institute in?
Allen Institute's product category is Bioscience Research Services. Its primary akta.pro industry code is HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization, with a secondary code of HLAAACAH, Neurology/CNS Gene Therapies. Its NAICS code is 541714 and its SIC code is 8731.